全文获取类型
收费全文 | 18984篇 |
免费 | 1774篇 |
国内免费 | 89篇 |
专业分类
耳鼻咽喉 | 144篇 |
儿科学 | 549篇 |
妇产科学 | 332篇 |
基础医学 | 2797篇 |
口腔科学 | 390篇 |
临床医学 | 2274篇 |
内科学 | 4033篇 |
皮肤病学 | 480篇 |
神经病学 | 1453篇 |
特种医学 | 768篇 |
外科学 | 3081篇 |
综合类 | 424篇 |
一般理论 | 10篇 |
预防医学 | 1605篇 |
眼科学 | 256篇 |
药学 | 1279篇 |
中国医学 | 12篇 |
肿瘤学 | 960篇 |
出版年
2021年 | 228篇 |
2020年 | 176篇 |
2019年 | 264篇 |
2018年 | 260篇 |
2017年 | 236篇 |
2016年 | 256篇 |
2015年 | 280篇 |
2014年 | 390篇 |
2013年 | 573篇 |
2012年 | 883篇 |
2011年 | 820篇 |
2010年 | 463篇 |
2009年 | 496篇 |
2008年 | 756篇 |
2007年 | 853篇 |
2006年 | 811篇 |
2005年 | 817篇 |
2004年 | 752篇 |
2003年 | 723篇 |
2002年 | 671篇 |
2001年 | 571篇 |
2000年 | 677篇 |
1999年 | 547篇 |
1998年 | 298篇 |
1997年 | 286篇 |
1996年 | 296篇 |
1995年 | 223篇 |
1994年 | 216篇 |
1993年 | 217篇 |
1992年 | 501篇 |
1991年 | 477篇 |
1990年 | 422篇 |
1989年 | 434篇 |
1988年 | 425篇 |
1987年 | 399篇 |
1986年 | 400篇 |
1985年 | 364篇 |
1984年 | 326篇 |
1983年 | 237篇 |
1982年 | 154篇 |
1981年 | 151篇 |
1980年 | 142篇 |
1979年 | 268篇 |
1978年 | 172篇 |
1977年 | 135篇 |
1976年 | 149篇 |
1975年 | 129篇 |
1974年 | 168篇 |
1973年 | 165篇 |
1972年 | 157篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
Physicians have long been wary of chronically administering neuroleptic drugs to the demented elderly for fear of significant side effects. In this article, the authors present evidence to support these fears. A discussion of the early and late emerging side effects of neuroleptic drugs is presented. 相似文献
13.
14.
L C Harlan B F Polk S Cooper T P Blaszkowski J Ignatius-Smith M Stromer H Mull 《American journal of preventive medicine》1986,2(5):256-261
The effects of labeling a person as hypertensive have important implications for hypertension screening. The Hypertension Detection and Follow-up Program (HDFP) provides an opportunity to examine the effects of labeling, treatment, and study assignment on a large group of hypertensives (n = 10,070). Their answers to questions regarding perceived health and general well-being asked at baseline and again one year later were analyzed. There was no significant change in the perceived health status of persons who were unaware of their hypertension at baseline and remained untreated at one year (labeling alone). The effect of labeling plus treatment was associated with a significant decrease in perceived health. The effect of antihypertensive drug therapy on perceived health status was examined in persons who were aware of their hypertension but not on treatment at baseline, and on treatment at one year. The stepped care group (SC) had a significant improvement in their perceived health and a significant decrease in the amount of time spent worrying about their health. The referred care group (RC) had no change. Program assignment effects were studied in individuals aware of their hypertension and on treatment both at baseline and one year later. Both the SC and RC groups had a significant improvement in their perceptions of their health status. The SC group had a significant decrease in time spent worrying about their health, while the RC group showed no change. These reassuring results fail to support the suggestion that labeling persons as hypertensive is necessarily followed by negative psychological consequences.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
15.
D. M. Reid I. Mackay S. Wilkinson C. Miller D. G. Schuette J. Compston C. Cooper E. Duncan N. Galwey R. Keen B. Langdahl A. McLellan H. Pols A. Uitterlinden J. O’Riordan J. A. H. Wass S. H. Ralston S. T. Bennett 《Osteoporosis international》2006,17(1):125-132
Osteoporosis is a common disease with a strong genetic component characterized by reduced bone mass and an increased risk of fragility fractures. Bone mineral density (BMD) is the most important determinant of osteoporotic fracture risk, but the genes responsible for BMD regulation and fracture are incompletely defined. To enable multi-center studies to examine the genetic influences on BMD there is a requirement to standardize measurements across different manufacturers of bone densitometers, different versions of machines and different normative ranges. This paper describes a method developed to allow near-identical subjects with low age-adjusted BMD (based on Z-scores) to be recruited in 17 centers using 27 different densitometers. Cross-calibration was based on measurements using a European spine phantom circulated to all centers and measured ten times on each individual machine. From theses values an individual exponential curve, based on nominal versus observed BMD, was derived for each machine. As expected, there were large and significant variations in nominal BMD values, not only between scanners from different manufacturers but also between different versions of scanners from the same manufacturer. Hologic scanners tended to underestimate the nominal BMD, while Lunar scanners overestimated the value. Norland scanners gave mixed values over estimating BMD at the lower nominal value (0.5 g/cm2) while underestimating the value at the higher value (1.5 g/cm2). The validity of the exponential equations was tested using hip and spine measurements on 991 non-proband women from a familial osteoporosis study (FAMOS). After cross-calibration there was a considerable reduction in variation between machines. This observation, coupled with the absence of a similar reduction in variation attributable to a linear regression on age, demonstrated the validity of the cross-calibration approach. Use of the cross-calibration curves along with a standard normative range (in the case of this study, the Hologic normative range) allowed age-specific Z-scores to be used as an inclusion criterion in this genetic study, a method that will be useful for other trials where age-specific BMD inclusion criteria are required. 相似文献
16.
Skoug John W. Borin Marie T. Fleishaker Joseph C. Cooper Anne M. 《Pharmaceutical research》1991,8(12):1482-1488
The mechanism of release from sustained-release adinazolam mesylate tablets was assessed by the Higuchi equation and by analysis of drug release profiles through 60% released using the Peppas equation. Computed values of the diffusional exponent, n, ranged from 0.59 to 0.66. Values of n in this range are consistent with a mixed mechanism of release, with diffusion of drug through the hydrated polymer matrix and relaxation of this matrix being the principal processes controlling release. The rate of in vitro drug release was increased for half tablets relative to whole tablets and is attributed to an increase in the surface to volume ratio of half tablets of about 16%. This increase in surface-to-volume ratio of half tablets was reflected by an increase in the constant, k, from the Peppas equation of 20–23% and by an increase in the slope of Higuchi plots of 12–18% for four lots of tablets. In vivo/in vitro relationships from two bioavailability studies were thoroughly evaluated. Using either a linear or a quadratic relationship, an in vivo/in vitro correlation exists for sustained-release adinazolam mesylate tablets. 相似文献
17.
18.
19.
20.